S&P 500   2,607.05 (+2.58%)
DOW   22,113.93 (+2.21%)
QQQ   191.23 (+3.20%)
AAPL   252.84 (+2.06%)
FB   163.87 (+4.52%)
MSFT   159.56 (+6.59%)
GOOGL   1,137.88 (+2.49%)
AMZN   1,956.42 (+2.96%)
CGC   14.70 (+0.75%)
NVDA   264.44 (+4.63%)
BABA   190.69 (+1.11%)
MU   45.06 (+3.63%)
GE   7.88 (+3.41%)
TSLA   506.78 (-1.47%)
AMD   48.12 (+3.31%)
T   30.07 (+0.77%)
ACB   0.93 (-9.71%)
F   5.04 (-3.08%)
NFLX   371.66 (+4.07%)
BAC   22.19 (+2.73%)
GILD   75.58 (+3.75%)
DIS   97.19 (+0.81%)
S&P 500   2,607.05 (+2.58%)
DOW   22,113.93 (+2.21%)
QQQ   191.23 (+3.20%)
AAPL   252.84 (+2.06%)
FB   163.87 (+4.52%)
MSFT   159.56 (+6.59%)
GOOGL   1,137.88 (+2.49%)
AMZN   1,956.42 (+2.96%)
CGC   14.70 (+0.75%)
NVDA   264.44 (+4.63%)
BABA   190.69 (+1.11%)
MU   45.06 (+3.63%)
GE   7.88 (+3.41%)
TSLA   506.78 (-1.47%)
AMD   48.12 (+3.31%)
T   30.07 (+0.77%)
ACB   0.93 (-9.71%)
F   5.04 (-3.08%)
NFLX   371.66 (+4.07%)
BAC   22.19 (+2.73%)
GILD   75.58 (+3.75%)
DIS   97.19 (+0.81%)
S&P 500   2,607.05 (+2.58%)
DOW   22,113.93 (+2.21%)
QQQ   191.23 (+3.20%)
AAPL   252.84 (+2.06%)
FB   163.87 (+4.52%)
MSFT   159.56 (+6.59%)
GOOGL   1,137.88 (+2.49%)
AMZN   1,956.42 (+2.96%)
CGC   14.70 (+0.75%)
NVDA   264.44 (+4.63%)
BABA   190.69 (+1.11%)
MU   45.06 (+3.63%)
GE   7.88 (+3.41%)
TSLA   506.78 (-1.47%)
AMD   48.12 (+3.31%)
T   30.07 (+0.77%)
ACB   0.93 (-9.71%)
F   5.04 (-3.08%)
NFLX   371.66 (+4.07%)
BAC   22.19 (+2.73%)
GILD   75.58 (+3.75%)
DIS   97.19 (+0.81%)
S&P 500   2,607.05 (+2.58%)
DOW   22,113.93 (+2.21%)
QQQ   191.23 (+3.20%)
AAPL   252.84 (+2.06%)
FB   163.87 (+4.52%)
MSFT   159.56 (+6.59%)
GOOGL   1,137.88 (+2.49%)
AMZN   1,956.42 (+2.96%)
CGC   14.70 (+0.75%)
NVDA   264.44 (+4.63%)
BABA   190.69 (+1.11%)
MU   45.06 (+3.63%)
GE   7.88 (+3.41%)
TSLA   506.78 (-1.47%)
AMD   48.12 (+3.31%)
T   30.07 (+0.77%)
ACB   0.93 (-9.71%)
F   5.04 (-3.08%)
NFLX   371.66 (+4.07%)
BAC   22.19 (+2.73%)
GILD   75.58 (+3.75%)
DIS   97.19 (+0.81%)
Log in

ASX:API - Australian Pharmaceutical Industries Stock Price, Forecast & News

A$1.19
+0.02 (+1.71 %)
(As of 03/30/2020 01:21 PM ET)
Today's Range
A$1.13
Now: A$1.19
A$1.19
50-Day Range
A$1.09
MA: A$1.22
A$1.32
52-Week Range
A$1.01
Now: A$1.19
A$1.57
Volume1.53 million shs
Average Volume1.60 million shs
Market Capitalization$586.26 million
P/E Ratio10.72
Dividend Yield6.84%
BetaN/A
Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. The company also retails health and beauty products to consumers; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and procedures. In addition, its services include wholesale product delivery, retail services, marketing programs, and business advisory services. The company markets its products and services under the Soul Pattinson Chemist, Pharmacist Advice, Club Premium, and Pharmacy Best Buys brand names, as well as through 475 Priceline and Priceline Pharmacy franchise stores, and company owned Priceline stores. Australian Pharmaceutical Industries Limited was founded in 1910 and is based in Camberwell, Australia.
Read More

Industry, Sector and Symbol

Industry Medical Equipment Wholesale
Sub-IndustryN/A
SectorServices
CUSIPN/A
CIKN/A
Phone+61-3-88553000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.01 billion
Cash FlowA$0.06 per share
Book ValueA$1.05 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$586.26 million
Next Earnings Date4/17/2020 (Estimated)
OptionableNot Optionable

Receive API News and Ratings via Email

Sign-up to receive the latest news and ratings for API and its competitors with MarketBeat's FREE daily newsletter.


Australian Pharmaceutical Industries (ASX:API) Frequently Asked Questions

How has Australian Pharmaceutical Industries' stock been impacted by COVID-19 (Coronavirus)?

Australian Pharmaceutical Industries' stock was trading at A$1.17 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, API stock has increased by 1.7% and is now trading at A$1.19. View which stocks have been mosted impacted by Coronavirus.

When is Australian Pharmaceutical Industries' next earnings date?

Australian Pharmaceutical Industries is scheduled to release its next quarterly earnings announcement on Friday, April 17th 2020. View our earnings forecast for Australian Pharmaceutical Industries.

How were Australian Pharmaceutical Industries' earnings last quarter?

Australian Pharmaceutical Industries Ltd (ASX:API) posted its quarterly earnings results on Wednesday, April, 17th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.05 by $0.00. View Australian Pharmaceutical Industries' earnings history.

How often does Australian Pharmaceutical Industries pay dividends? What is the dividend yield for Australian Pharmaceutical Industries?

Australian Pharmaceutical Industries announced a final dividend on Monday, October 28th. Stockholders of record on Thursday, December 12th will be paid a dividend of 0.04 per share on Thursday, December 12th. This represents a dividend yield of 2.93%. The ex-dividend date of this dividend is Wednesday, November 13th. View Australian Pharmaceutical Industries' dividend history.

Has Australian Pharmaceutical Industries been receiving favorable news coverage?

News headlines about API stock have been trending very positive on Monday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Australian Pharmaceutical Industries earned a news sentiment score of 4.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutAustralian Pharmaceutical Industries.

Who are some of Australian Pharmaceutical Industries' key competitors?

What other stocks do shareholders of Australian Pharmaceutical Industries own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Australian Pharmaceutical Industries investors own include Harvey Norman (HVN), Evolution Mining (EVN), Downer EDI (DOW) and Austal (ASB).

Who are Australian Pharmaceutical Industries' key executives?

Australian Pharmaceutical Industries' management team includes the following people:
  • Mr. Richard C. Vincent B.Bus, (Accountancy), CPA, MD, CEO & Exec. Director
  • Mr. Peter Mendo, Chief Financial Officer
  • Mr. Dean Matthews, Chief Information Officer
  • Mr. Peter F. Sanguinetti, Gen. Counsel & Company Sec. (Age 63)
  • Mr. Stephen Arthurson, Gen. Mang. of People

What is Australian Pharmaceutical Industries' stock symbol?

Australian Pharmaceutical Industries trades on the ASX under the ticker symbol "API."

What is Australian Pharmaceutical Industries' stock price today?

One share of API stock can currently be purchased for approximately A$1.19.

How big of a company is Australian Pharmaceutical Industries?

Australian Pharmaceutical Industries has a market capitalization of $586.26 million and generates $4.01 billion in revenue each year.  View additional information about Australian Pharmaceutical Industries.

What is Australian Pharmaceutical Industries' official website?

The official website for Australian Pharmaceutical Industries is http://www.api.net.au/.

How can I contact Australian Pharmaceutical Industries?

Australian Pharmaceutical Industries' mailing address is L 5 250 Camberwell Rd, MELBOURNE, VIC 3124, Australia. The company can be reached via phone at +61-3-88553000.


MarketBeat Community Rating for Australian Pharmaceutical Industries (ASX API)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  43 (Vote Outperform)
Underperform Votes:  49 (Vote Underperform)
Total Votes:  92
MarketBeat's community ratings are surveys of what our community members think about Australian Pharmaceutical Industries and other stocks. Vote "Outperform" if you believe API will outperform the S&P 500 over the long term. Vote "Underperform" if you believe API will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/30/2020 by MarketBeat.com Staff

Featured Article: 52-Week High/Low

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel